BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:HRS-9190 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of HRS-9190\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07746726-11078@assetmemo.bio
DTSTAMP:20261121T004109Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:HRS-9190: Phase 3 readout est. (NCT07746726)
DESCRIPTION:HRS-9190\, phase 3.\nStudy: Safety and Efficacy of HRS-9190 Com
 pared to Rocuronium for Tracheal Intubation and Bolus Maintenance in Adult
 s\nEstimated primary completion: 31 December 2026. This is a ClinicalTrial
 s.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pag
 e: https://assetmemo.bio/drug/hrs-9190#upcoming-events\nRegistry record: h
 ttps://clinicaltrials.gov/study/NCT07746726
URL:https://assetmemo.bio/drug/hrs-9190#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07733245-11078@assetmemo.bio
DTSTAMP:20261121T004109Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:HRS-9190: Phase 3 readout est. (NCT07733245)
DESCRIPTION:HRS-9190\, phase 3.\nStudy: Efficacy and Safety of HRS-9190 in 
 General Anesthesia\nEstimated primary completion: 31 December 2026. This i
 s a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it ca
 n move.\nDrug page: https://assetmemo.bio/drug/hrs-9190#upcoming-events\nR
 egistry record: https://clinicaltrials.gov/study/NCT07733245
URL:https://assetmemo.bio/drug/hrs-9190#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
